VitaHustle® Launches at The Vitamin Shoppe® to Bring Clean, All-in-One Nutrition to Consumers Nationwide
LOS ANGELES, June 5, 2025 /PRNewswire/ -- VitaHustle, the wellness brand founded by entertainer and entrepreneur Kevin Hart, is excited to announce the nationwide launch of its flagship product, VitaHustle ONE, at The Vitamin Shoppe®. Now available in-store, online, and via Instacart, VitaHustle ONE delivers a clean, convenient solution to daily nutrition—combining protein, essential vitamins, superfoods, and probiotics in one delicious shake.
With a growing demand for simple, effective wellness solutions, VitaHustle ONE replaces your daily multivitamin with a shake that supports protein intake, mood, energy, gut health, and overall wellness. Its clean-label formulation is 100% plant-based and free of preservatives, added sugars, and the top nine allergens.
"The Vitamin Shoppe provides the education and access needed to bring VitaHustle to consumers nationwide," said Kevin Hart, co-founder of VitaHustle. "Our mission is to simplify wellness, and by partnering with The Vitamin Shoppe, we're able to make VitaHustle ONE Superfood Protein available to even more people who want clean, convenient, and damn delicious nutrition."
Following the success of VitaHustle ONE Superfood Protein, VitaHustle ONE Lean Protein & GLP-1 Support is now also available, exclusively at The Vitamin Shoppe. This lower-calorie formulation builds on the core benefits of VitaHustle ONE and includes targeted ingredients that help support appetite control.
"We're thrilled to add Kevin Hart's VitaHustle ONE product line to our industry-leading assortment at The Vitamin Shoppe. Today's wellness consumers are actively seeking out simplified and effective, on-the-go daily nutrition solutions—and VitaHustle ONE delivers an exceptional option with science-backed, high-quality ingredients, in a delicious and convenient product," said Muriel Gonzalez, President of The Vitamin Shoppe.
VitaHustle ONE and VitaHustle ONE Lean are available at The Vitamin Shoppe locations nationwide and online at www.vitaminshoppe.com.
About VitaHustle
VitaHustle®, founded by Kevin Hart, is on a mission to simplify daily nutrition and empower individuals to live healthier lives — without the complexity of supplements, pills, or meal prep. Its clean, all-in-one daily nutrition shake is made with plant-based protein, superfoods, vitamins, probiotics, and adaptogens — delivering complete wellness in one delicious serving. Since launching in 2022, VitaHustle has quickly emerged as a fast-scaling brand, selling over 1 million products with thousands of 5-star reviews from customers who have made VitaHustle part of their daily routine. The brand's community-first approach, field marketing and social activations have helped fuel rapid growth across the space. With more innovative products on the horizon, VitaHustle continues to expand its footprint both online and in retail, redefining how people approach daily wellness — one shake at a time. Products are available online at www.vitahustle.com, on QVC, and now nationwide at The Vitamin Shoppe and Sprouts. For more information, visit www.vitahustle.com.
About The Vitamin Shoppe
Lifelong Wellness Starts Here™. The Vitamin Shoppe® is a global, omnichannel specialty retailer and wellness lifestyle Company with the mission of providing customers with the most trusted products, guidance, and services to support them on their journeys of lifelong wellness. Based in Secaucus, New Jersey, the Company offers a comprehensive assortment of nutritional solutions, including vitamins, minerals, sports nutrition, specialty supplements, herbs, homeopathic remedies, and green living products. In addition to carrying products from approximately 700 national brands, The Vitamin Shoppe offers products from its proprietary brands within its owned and wholesale channels, including: The Vitamin Shoppe®, Vthrive The Vitamin Shoppe®, BodyTech®, BodyTech® Elite, plnt®, ProBioCare®, True Athlete®, and Whole Health Rx™. In the U.S., the Company conducts business through over 635 company-operated retail stores under The Vitamin Shoppe and Super Supplements™ banners and via its website, www.vitaminshoppe.com. Globally, The Vitamin Shoppe serves customers in select Asia, South America, and Central America markets through local omnichannel partners.
For more information or to shop online, visit www.vitaminshoppe.com or follow @VitaHustle on social media.
Media Contact:Kristin Chadwickkristin@vitahustle.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vitahustle-launches-at-the-vitamin-shoppe-to-bring-clean-all-in-one-nutrition-to-consumers-nationwide-302474016.html
SOURCE VitaHustle
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
6 hours ago
- The Hill
Americans' becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows. The YouGov poll, released Friday, shows that at least 80 percent of respondents have heard at least 'a little bit' about semaglutide, a medication used to treat Type 2 diabetes that also helps a user to shed weight. In March 2023, only 60 percent of Americans were aware of the drug. A year later, in March 2024, that number had jumped to 70 percent, the pollster noted. The latest survey also shows that the share of those who have heard 'a lot' about the medication has nearly doubled since 2023, increasing to 41 percent from 23 percent. Just 36 percent of respondents say they know someone who has taken semaglutide. Around 14 percent listed a family member took the medicine, 16 percent named a friend, 11 percent identified an acquaintance and 7 percent said they had taken it themselves, according to the poll. Several also noted they knew a user in more than one category. Women are more likely than men, 43 percent to 29 percent, to know someone — including themselves — who has taken a GLP-1 agonist drug, per the survey. The weight loss medications — including Wegovy, Ozempic, Zepbound and others — have been available since 2005 but have only in the past few years been used to treat obesity. The drugs work by mimicking a hormone in the body — glucagon-like peptide-1 — that stimulates insulin secretion and reduces appetite. Possible side effects of taking the medication include nausea, diarrhea, vomiting, and constipation. While semaglutide is currently only prescribed for weight loss or treating diabetes, early research is pointing to possible benefits for a host of other issues, including treatment for addiction, neurodegenerative diseases and conditions that affect the heart, kidney or liver. The latest survey found that roughly a quarter of respondents said they would be 'very' or 'somewhat' interested in taking the medication as a weight loss treatment. About a third of Americans have either taken the drug or said they would be interested in trying it. On the other side, about 17 percent said they were 'not very' interested in the medication and 45 percent signaled they were not at all interested. A separate poll from last September found that around a quarter of adults in the U.S. would consider using weight loss medications without consulting their doctor. The YouGov analysis is based on an online survey conducted from May 22-25 among 1,109 adults in the U.S. The margin of error for the full sample is 4 percentage points.
USA Today
21 hours ago
- USA Today
Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition
Eagles running back Saquon Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trumps Council on Sports, Fitness, and Nutrition.' Saquon Barkley is a son, a fantastic father, the NFL's Offensive Player of the Year winner, and now a member of President Donald Trump's administration. In a move that will revive a standard from the Reagan, Clinton, and Bush era, Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trump's Council on Sports, Fitness, and Nutrition.' According to the Washington Post, President Trump on Thursday announced that the presidential fitness test, a hallmark of American physical education programs, will be making a comeback in public schools. The assessment was retired and replaced by a fitness program under the Obama administration. The presidential fitness test was initiated in the 1950s by a council established by President Dwight D. Eisenhower that was directed to improve the physical fitness of American youths, in response to fears they were falling behind their European counterparts when it came to athleticism. The project is an alternative way to get anti-obesity drugs to Medicare and Medicaid patients, after the administration said in April that neither program would cover GLP-1s for weight loss. In doing so, it scrapped a 2024 Biden administration proposal for the programs to start covering GLP-1s for patients with obesity. Several high-profile athletes — all of whom have existing ties to Trump — attended the ceremony and will serve on the President's Council on Sports, Fitness and Nutrition. The attendees included professional golfer Bryson DeChambeau, who will chair the council; controversial National Football League kicker Harrison Butker; World Wrestling Entertainment mainstay Paul 'Triple H' Levesque; golfer Annika Sorenstam; and football Hall of Famer Lawrence Taylor. The Eagles running back wasn't in attendance, but will be joined by golfers Jack Nicklaus, Nelly Korda, and Gary Player (who was also awarded the Medal of Freedom alongside Sorenstam); Tony Romo, Nick Bosa, and Barkley; legendary hockey player Wayne Gretzky; and baseball player Mariano Rivera. The list also includes NFL Commissioner Roger Goodell, whom Trump repeatedly scrutinized during his first presidential term. Barkley was criticized during the off-season for spending time with President Trump on a golf outing prior to the Eagles' ring celebration.
CNBC
a day ago
- CNBC
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
CNBC's Jim Cramer walked investors through another week of earnings season, honing in on reports from Palantir, Berkshire Hathaway, Disney and Eli Lilly. "We're still in earnings Hades, but at least it's getting a little cooler out there," he said. "That's right, we've now gotten over the hump of the big-time growth stocks, the hyperscalers, but there's plenty left." On Saturday, Cramer will be paying attention to earnings from Berkshire Hathaway, and he suggested things might be a little different with Greg Abel at the helm. If the report is good, Cramer said he bets the stock goes higher. Monday, Cramer is watching Palantir's report. He has called the company, which just landed a $10 billion Army contract, "the most controversial stock in the entire market." He said the data outfit has excited many on Wall Street. And he predicted the quarter will be "a total blowout," as it seems business is strong. Tuesday brings quarterly results from DuPont De Nemours, Caterpillar, Pfizer and Marriott. Cramer said it's important to see that DuPont's breakup is on track, because the parts are worth more than the whole for the chemical company. He suggested Caterpillar will post strong results as the equipment manufacturer rides the tailwinds of domestic infrastructure and reshoring. To Cramer, it's necessary that Pfizer sees some "really dramatic" results from clinical trials because the pharmaceutical giant's shareholder base is "getting very restive." Marriott is usually reliable, he continued, but said the hotel chain's stock tends to come down after earnings even if the results are good. Disney and McDonald's are set to report on Wednesday. Shares of the media titan have been climbing nicely, Cramer said, and he praised the streaming, theme park and cruise line business segments. He also said McDonald's is a buy at current levels, suggesting the company has improved as of late with new offerings for customers. Dutch Bros and E.l.f Beauty, two young "renegade" companies that have shaken up business in their respective sectors, will also report Wednesday, Cramer said. He added that he thinks they both have room to grow and take share. Thursday brings earnings from Eli Lilly. Cramer pointed out that its main competitor in the GLP-1 drug arena, Novo Nordisk, just posted a disappointing quarter. He wondered whether Novo Nordisk's results indicate that Eli Lilly has been taking share or if both companies are seeing a peak in their popular weight loss medication. He said both dynamics could be true. Warner Bros Discovery, MP Materials, Wynn Resorts and Pinterest are also set to report on Thursday. Cramer said he's waiting to hear how Warner Bros is reorganizing the company and paying down debt. He said he wants to learn about rare earth mineral miner MP Materials' deal with the U.S. government. He also said he's feeling positive about Wynn Resorts. Pinterest is likely to post a solid report, he continued, and said it's the most family-friendly advertising platform compared to its peers. Wendy's will post earnings on Friday, and Cramer said the previous quarter was weak. He suggested the sector is so competitive that there are no guarantees the burger chain will share good results. Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest The CNBC Investing Club Charitable Trust owns share of DuPont de Nemours, Disney and Eli Lilly.
